JSZ ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENSES FOR OVERNIGHT WEAR

Lens, Contact, Orthokeratology, Overnight

FDA Premarket Approval P040029

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the jsz orthokeratology (oprifocon a) contact lenses for overnight wear. The lenses are indicated for use in the reduction of myopic refractive error in non-diseased eyes. The lenses are indicated for overnight wear for the temporary reduction of myopia up to 5. 00 diopters with eyes having astigmatism up to 1. 50 diopters. The lenses may only be disinfected using a chemical disinfection system. Note: to maintain the orthokeratology effect of myopia reduction, overnight lens wear must be continued on a prescribed schedule. Failure to do so can affect daily activities (e. G. , night driving), visual fluctuations and changes in intended correction.

DeviceJSZ ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENSES FOR OVERNIGHT WEAR
Classification NameLens, Contact, Orthokeratology, Overnight
Generic NameLens, Contact, Orthokeratology, Overnight
ApplicantEuclid Systems Corporation
Date Received2004-06-21
Decision Date2004-09-29
Notice Date2004-10-12
PMAP040029
SupplementS
Product CodeNUU
Docket Number04M-0450
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Euclid Systems Corporation 2776 Towerview Rd. herndon, VA 20171
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040029Original Filing
S020 2021-06-29 30-day Notice
S019 2021-01-14 30-day Notice
S018
S017
S016 2020-08-12 Normal 180 Day Track No User Fee
S015 2020-05-29 Normal 180 Day Track
S014 2020-02-26 Normal 180 Day Track No User Fee
S013
S012 2020-01-31 30-day Notice
S011
S010
S009 2019-06-26 Normal 180 Day Track
S008 2019-05-08 Real-time Process
S007 2019-03-15 30-day Notice
S006
S005 2017-08-09 30-day Notice
S004 2016-12-27 Normal 180 Day Track
S003 2016-01-29 Normal 180 Day Track No User Fee
S002 2015-08-03 Normal 180 Day Track No User Fee
S001 2005-08-29 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
85000713500232 P040029 000
85000713599960 P040029 000
85000713599991 P040029 000
85000713599984 P040029 000
85000713500102 P040029 000
85000713500119 P040029 000
85000713500126 P040029 000
85000713500133 P040029 000
85000713500140 P040029 000
85000713500157 P040029 000
85000713500164 P040029 000
85000713500171 P040029 000
85000713500188 P040029 000
85000713500195 P040029 000
85000713500218 P040029 000
85000713500225 P040029 000
85000713599977 P040029 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.